CytoDyn's 'interviews' continue to get visibility especially when we as shareholders help get them on social media and the like.... and new eyes check out their website.

Quote:

---

Fortunately, COVID-19 is a big enough issue that leronlimab as a treatment can't help but (eventually) rise to the top in the national discussion.

---

Agree the above will win out!

Think Dr. Pourhassan said the VIP was from California...